Vai al contenuto
Claris Ventures
  • Home
  • About us
  • Strategy
  • Team
  • News
  • Careers
Settembre 1, 2020

Primo closing a quota €30m per Claris Biotech I, fondo biotech promosso da Claris Ventures SGR Torino, 1 settembre 2020 – Claris Ventures...READ MORE

CLARIS VENTURES LANCIA UN FONDO DEDICATO AL BIOTECH ITALIANO

Aprile 7, 2020

La rivista Prisma dedica un articolo a Claris Ventures La rivista Prisma nel mese di aprile dedica un articolo a Claris Ventures.  Eloisa...READ MORE

Claris Ventures sulla rivista Prisma di Aprile

Aprile 7, 2020

Covid-19: new report from Claris Ventures on development of drugs and vaccines Claris Ventures pubblished a Vaccines & Treatments Development Snapshot for Covid-19...READ MORE

COVID-19: Claris Ventures publishes its report on vaccines and drugs in development

Aprile 7, 2020

Business Insider: Claris, il primo fondo di venture capital italiano che investe solo nel biotech tricolore Ciro Spedaliere, Managing Partner of Claris Ventures,...READ MORE

Business Insider: Claris, il primo fondo di venture capital italiano che investe solo nel biotech tricolore

Febbraio 14, 2020

Ciro Spedaliere from Claris Ventures in the Life Science Panel of Aifi VentureUp Forum 2020 Ciro Spedaliere, Partner of Claris Ventures, will be...READ MORE

VentureUp Forum 2020

Novembre 16, 2019

Claris Ventures special guest at 39° Congresso Nazionale della Società Italiana di Farmacologia (SIF) The 39° National Congress of the Italian Pharmacology Society...READ MORE

Claris Ventures special guest at 39° Congresso Nazionale della Società Italiana di Farmacologia (SIF)

Ottobre 25, 2019

Claris Ventures joins Torino City Lab

Claris Ventures joins Torino City Lab

Luglio 5, 2019

Kither Biotech raises a €5.6m financing round to support the clinical development of a new drug for cystic fibrosis and other pulmonary diseases...READ MORE

Kither Biotech raises a €5.6m financing round to support the clinical development of a new drug for cystic fibrosis and other pulmonary diseases

Maggio 20, 2019

Claris Ventures guest speaker at “The drug from basic research to therapy” convention organized by the Italian Society of Pharmacology

Claris Ventures guest speaker at “The drug from basic research to therapy” convention organized by the Italian Society of Pharmacology

Maggio 2, 2019

Pietro Puglisi of Claris Ventures, interviewed by national TV RAI

Pietro Puglisi from Claris Ventures interviewed by national TV

Links

  • Claris Ventures
  • Team
  • About us
  • Strategy
  • Privacy Policy
  • Terms of Service
  • News
  • Biotech News
  • Analyst
  • Careers
  • Trasparenza
  • CEO Portfolio Company

Contacts

Via Santa Giulia 1, Torino, Italy
+39 (0) 11 3325889
info@clarisventures.com

Arbitro per le Controversie Finanziarie

VAT: 12116290011

PEC: clarisventures.pec [at] maildoc.it

Stay in touch with Claris Ventures

Sign up for our newsletter to stay up to date on news from Claris, and our portfolio.

This website stores cookies on your computer. These cookies are used to improve your website and provide more personalized services to you, both on this website and through other media. To find out more about the cookies we use, read the privacy policy
Proudly powered by WordPress | Tema: Sydney by aThemes.